D. Baratti

发表

The Delphi approach to Attain consensus in methodology of local regional therapy for peritoneal surface malignancy

M. Deraco, S. Kusamura, R. Younan, 2008, Journal of surgical oncology.

Survivin is Highly Expressed and Promotes Cell Survival in Malignant Peritoneal Mesothelioma

M. Daidone, N. Zaffaroni, M. Pennati, 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Post-absorptive and insulin-mediated muscle protein metabolism in liver-transplanted patients

V. Mazzaferro, A. Pulvirenti, E. Regalia, 2002, Acta Diabetologica.

Effect of liver transplantation in cirrhotic diabetic patients.

V. Mazzaferro, E. Regalia, L. Luzi, 1998, Transplantation proceedings.

Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791).

L. Battaglia, M. Deraco, S. Kusamura, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Impact of Previous Gynecologic Surgical Procedures on Outcomes of Non-Gynecologic Peritoneal Malignancies Mimicking Ovarian Cancer: Less Is More?

L. Battaglia, M. Deraco, S. Kusamura, 2021, Annals of Surgical Oncology.

Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantation

V. Mazzaferro, A. Pulvirenti, E. Regalia, 2000, Hepatology.

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases

S. Bonomi, M. Milione, E. Leo, 2016, Annals of Surgical Oncology.

Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

P. Faviana, M. Vaira, P. Sammartino, 2021, Annals of Surgical Oncology.

Preoperative chemoradiation in patients with resectable rectal cancer: Results on tumor response

F. Valvo, L. Mariani, S. Andreola, 2002, Annals of Surgical Oncology.

Preoperative radiation therapy for patients with T2–T3 carcinoma of the middle‐to‐lower rectum

L. Mariani, R. Zucali, M. Schiavo, 1999, Cancer.

Surgical treatment of locally recurrent rectal carcinoma

S. Andreola, F. Bozzetti, L. Gennari, 1997, Diseases of the colon and rectum.

Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI).

M. Pocard, M. Hübner, D. Morris, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review.

F. Pietrantonio, M. Deraco, S. Kusamura, 2016, Critical reviews in oncology/hematology.

Low‐dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis

P. Casali, S. Pilotti, A. Ferrari, 2001, Cancer.

The Role of Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

M. Deraco, S. Kusamura, D. Baratti, 2013, Annals of Surgical Oncology.

Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma

M. Daidone, R. Reddel, N. Zaffaroni, 2008, Clinical Cancer Research.

Multiple Mechanisms of TelomereMaintenance Exist and DifferentiallyAffect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma

M. Daidone, R. Reddel, N. Zaffaroni, 2008 .

Advances in clinical research and management of diffuse peritoneal mesothelioma.

N. Zaffaroni, M. Deraco, S. Kusamura, 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy

M. Deraco, S. Kusamura, R. Younan, 2008, Journal of surgical oncology.

Hemodynamic and respiratory implications of high intra-abdominal pressure during HIPEC.

F. Valenza, M. Deraco, S. Kusamura, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).

M. Deraco, S. Kusamura, A. Cabras, 2008, In vivo.

Impact of Distal Clearance Margin on Oncologic Outcome after Restorative Resection of the Rectum

L. Mariani, R. Miceli, S. Andreola, 1997, Tumori.

Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer

R. Bristow, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

A. Scivales, M. Deraco, S. Kusamura, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

CDX‐2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases

P. Casali, D. Nonaka, M. Deraco, 2006, Histopathology.

Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study.

S. Msika, F. Guyon, B. Rau, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma.

M. Pierotti, S. Pilotti, F. Perrone, 2010, European journal of cancer.

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi‐institutional experience

M. Pocard, D. Morris, P. Piso, 2018, Journal of surgical oncology.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.

M. Solazzo, S. Bonomi, M. Deraco, 2011, Gynecologic oncology.

Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer.

P. Ravenda, M. Deraco, S. Kusamura, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal Metastases

F. Perrone, M. Milione, F. Pietrantonio, 2020, Annals of Surgical Oncology.

Cytoreductive Surgery and HIPEC in the First-Line and Interval Time Points of Advanced Epithelial Ovarian Cancer

M. Deraco, S. Kusamura, D. Baratti, 2017, Indian Journal of Gynecologic Oncology.

Preoperative serum levels of wild‐type and hepatitis B e antigen‐negative hepatitis B virus (HBV) and graft infection after liver transplantation for HBV‐related hepatocellular carcinoma

V. Mazzaferro, A. Pulvirenti, E. Regalia, 1997, Journal of viral hepatitis.

Peritoneal Mesothelioma: Diagnosis and Management

M. Deraco, S. Kusamura, A. Cabras, 2019, Mesothelioma.

Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types

T. Negri, S. Pilotti, S. Stacchiotti, 2018, Journal of immunology research.

Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC

M. Deraco, S. Kusamura, D. Baratti, 2022, Annals of Surgical Oncology.

Systemic metastases from low-grade and high-grade pseudomyxoma peritonei: Treatments and outcomes.

M. Deraco, S. Kusamura, D. Baratti, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin.

F. Mangili, A. Siccardi, G. Paganelli, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

M. Milione, M. Deraco, S. Kusamura, 2018, Annals of Surgical Oncology.

Technical aspects of cytoreductive surgery

S. O'dwyer, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy

M. Deraco, S. Kusamura, R. Younan, 2008, Journal of surgical oncology.

The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4–6, 2006): methodology of disease‐specific consensus

M. Deraco, S. Kusamura, D. Baratti, 2008, Journal of surgical oncology.

ASO Author Reflections: Management of Recurrent Pseudomyxoma Peritonei After Cytoreductive Surgery and HIPEC

M. Deraco, D. Baratti, 2022, Annals of Surgical Oncology.

Toward the molecular dissection of peritoneal pseudomyxoma.

F. D. De Braud, F. Perrone, A. Busico, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS)

M. Deraco, S. Kusamura, D. Baratti, 2019, Annals of Surgical Oncology.

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery

T. Chua, J. Pelz, J. Esquivel, 2014, Journal of surgical oncology.

Management and complete resection of peritoneal and bone metastases from mucinous rectal carcinoma

L. Battaglia, M. Deraco, M. Cosimelli, 2020, Tumori.

Cytoreductive Surgery and HIPEC for the Prevention and Treatment of Colorectal Peritoneal Metastases: Lessons Learnt from Three Recent Randomized Trials

D. Baratti, M. Guaglio, L. Sorentino, 2020 .

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

B. Rau, S. Ahrendt, M. Pocard, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Peritoneal Mesothelioma: Disease Biology and Patterns of Peritoneal Dissemination

F. Perrone, N. Zaffaroni, M. Deraco, 2020 .

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement

L. Oñate-Ocaña, N. Petrelli, D. Shibata, 2007, Annals of Surgical Oncology.

Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study.

D. Morelli, M. Deraco, S. Kusamura, 2018, European Journal of Surgical Oncology.

In Reply: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must Be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma

M. Deraco, S. Kusamura, A. Cabras, 2010, Annals of Surgical Oncology.

Modalities of Hyperthermic Intraperitoneal Chemotherapy

M. Deraco, D. Baratti, Kusamura Shigeki, 2008, Annals of Surgical Oncology.

Carboplatin plus paclitaxel scheduling for advanced ovarian cancer.

M. Deraco, S. Kusamura, D. Baratti, 2014, The Lancet. Oncology.

Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

M. Vaira, M. Deraco, S. Kusamura, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Multicystic and Well-differentiated Papillary Peritoneal Mesothelioma Treated by Surgical Cytoreduction and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

D. Nonaka, M. Deraco, S. Kusamura, 2007, Annals of Surgical Oncology.

Epidural analgesia for cytoreductive surgery with peritonectomy and heated intraperitoneal chemotherapy.

M. Deraco, S. Kusamura, D. Baratti, 2015, International journal of surgery.

The nanomechanical fingerprint of colorectal-derived peritoneal metastasis

M. Gariboldi, A. Podestà, M. Deraco, 2022, bioRxiv.

Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: Analysis of two centres

S. Bonomi, M. Deraco, S. Kusamura, 2013, Journal of surgical oncology.

Consensus statement on the loco‐regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)

B. Moran, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

S. Andreola, D. Nonaka, M. Deraco, 2008, Annals of Surgical Oncology.

Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes

M. Milione, F. Morano, F. Pietrantonio, 2022, Annals of Surgical Oncology.

Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

M. Deraco, S. Kusamura, D. Baratti, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study

M. Milione, F. Pietrantonio, M. Deraco, 2016, Annals of Surgical Oncology.

Identification of a Subgroup of Patients at Highest Risk for Complications After Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

M. Deraco, S. Kusamura, D. Baratti, 2012, Annals of surgery.

Correction to: Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series

M. Milione, L. Battaglia, F. Pietrantonio, 2018, Annals of Surgical Oncology.

Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series

M. Milione, L. Battaglia, F. Pietrantonio, 2017, Annals of Surgical Oncology.

An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

S. Msika, F. Guyon, B. Rau, 2022, World Journal of Surgery.

Early and long-term outcome data on 2,298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

T. Chua, D. Morris, D. Elias, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chordoma: Natural History and Results in 28 Patients Treated at a Single Institution

A. Gronchi, M. Colecchia, M. Fiore, 2003, Annals of Surgical Oncology.

External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

M. Vaira, P. Sammartino, P. Del Bianco, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC

M. Deraco, S. Kusamura, D. Baratti, 2022, Annals of Surgical Oncology.

Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPEC

M. Deraco, S. Kusamura, D. Baratti, 2018, Annals of Surgical Oncology.

Preoperative radiotherapy for resectable cancer of the middle-distal rectum: its effect on the primary lesion as determined by endorectal ultrasound using flexible echo colonoscope

R. Zucali, S. Andreola, R. Doci, 1996, International Journal of Colorectal Disease.

The consensus statement on the locoregional treatment of abdominal sarcomatosis

P. Casali, C. Rossi, M. Deraco, 2008, Journal of surgical oncology.

Chemotherapy of peritoneal disseminations of colorectal origin

M. Deraco, S. Kusamura, D. Baratti, 2014 .

Circulating CA125 and diffuse malignant peritoneal mesothelioma.

M. Deraco, S. Kusamura, D. Baratti, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies

M. Deraco, S. Kusamura, D. Baratti, 2009, Journal of surgical oncology.

Preliminary results of a program for the implementation of laparoscopic colorectal surgery in an Italian comprehensive cancer center during the COVID-19 pandemic

L. Battaglia, M. Deraco, S. Kusamura, 2022, Updates in Surgery.

Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience.

M. Deraco, S. Kusamura, D. Baratti, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases

S. Bonomi, M. Deraco, S. Kusamura, 2013, Tumori.

Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases.

S. Bonomi, M. Deraco, S. Kusamura, 2013, Tumori.

The nanomechanical fingerprint of colorectal cancer-derived peritoneal metastasis

M. Gariboldi, A. Podestà, M. Deraco, 2022, bioRxiv.

Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis

M. Vaira, I. Sperduti, P. Sammartino, 2022, Cancers.

Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy

M. Deraco, S. Kusamura, D. Baratti, 2008, Journal of surgical oncology.

Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity

F. Grosso, M. Deraco, S. Kusamura, 2007, Annals of Surgical Oncology.

Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

M. Deraco, S. Kusamura, D. Baratti, 2010, World journal of gastrointestinal oncology.

Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy

M. Deraco, S. Kusamura, R. Younan, 2007, Annals of Surgical Oncology.

Morbidity and quality of life following cytoreduction and HIPEC.

M. Deraco, S. Kusamura, D. Baratti, 2007, Cancer treatment and research.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

T. Chua, D. Morris, P. Piso, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination

J. Esquivel, D. Elias, M. Deraco, 2008, Journal of surgical oncology.

FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma.

G. Pelosi, F. D. De Braud, F. Perrone, 2014, The oncologist.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

T. Chua, J. Pelz, D. Morris, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Decellularized Normal and Tumor Extracellular Matrix as Scaffold for Cancer Organoid Cultures of Colorectal Peritoneal Metastases

M. Gariboldi, G. Pruneri, M. Pierotti, 2021, bioRxiv.

Experience with peritoneal mesothelioma at the Milan National Cancer Institute.

S. Pilotti, F. Perrone, N. Zaffaroni, 2010, World journal of gastrointestinal oncology.

Diffuse Malignant Peritoneal Mesothelioma: Failure Analysis Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

P. Dileo, M. Deraco, S. Kusamura, 2009, Annals of Surgical Oncology.

Diffuse malignant mesothelioma of the peritoneum

P. Casali, J. Rosai, D. Nonaka, 2005, Cancer.

Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

E. Seregni, M. Deraco, S. Kusamura, 2007, Annals of Surgical Oncology.

Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

P. Casali, J. Rosai, D. Nonaka, 2006, Annals of Surgical Oncology.

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion

P. Casali, R. Bertulli, M. Deraco, 2003, Journal of surgical oncology.

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

V. Mazzaferro, A. Pulvirenti, E. Regalia, 1997, Transplantation proceedings.

Pathophysiology and biology of peritoneal carcinomatosis.

N. Zaffaroni, R. Villa, M. Deraco, 2010, World journal of gastrointestinal oncology.

The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis

T. Chua, J. Pelz, J. Esquivel, 2014, Annals of Surgical Oncology.

Well differentiated papillary peritoneal mesothelioma treated by cytoreduction and hyperthermic intraperitoneal chemotherapy-the experience of the PSOGI registry.

J. Tuech, M. Deraco, S. Kusamura, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Multicystic mesothelioma: Operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy.

M. Deraco, S. Kusamura, A. Cabras, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei.

F. D. De Braud, M. Milione, F. Morano, 2019, Clinical colorectal cancer.

Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei

S. Andreola, M. Deraco, S. Kusamura, 2004, Annals of Surgical Oncology.

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma

M. Dugo, N. Zaffaroni, G. Colella, 2022, Cancer Gene Therapy.

Diffuse malignant peritoneal mesothelioma: Systematic review of clinical management and biological research

M. Deraco, S. Kusamura, D. Baratti, 2011, Journal of surgical oncology.

The eligibility for local‐regional treatment of peritoneal surface malignancy

M. Deraco, S. Kusamura, D. Baratti, 2008, Journal of surgical oncology.

Hyperthermic intraperitoneal chemotherapy: Nomenclature and modalities of perfusion

E. Cotte, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion

M. Deraco, S. Kusamura, R. Younan, 2006, Cancer.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement

L. Oñate-Ocaña, N. Petrelli, D. Shibata, 2006, Annals of Surgical Oncology.

Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.

M. Deraco, S. Kusamura, D. Baratti, 2003, Journal of experimental & clinical cancer research : CR.

Bowel Complications in 203 Cases of Peritoneal Surface Malignancies Treated With Peritonectomy and Closed-Technique Intraperitoneal Hyperthermic Perfusion

M. Deraco, S. Kusamura, R. Younan, 2005, Annals of Surgical Oncology.

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.

J. Pelz, D. Morris, P. Piso, 2021, JAMA surgery.

Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry

M. Simone, K. Chouliaras, D. Morris, 2018, Annals of Surgical Oncology.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal Surface Malignancies Oncoteam—S.I.C.O.’

F. Roviello, D. Marrelli, L. Marano, 2021, Annals of Surgical Oncology.

Regulation of glucose homeostasis in humans with denervated livers.

V. Mazzaferro, A. Pulvirenti, E. Regalia, 1997, The Journal of clinical investigation.

Epithelioid Sarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution

P. Casali, A. Gronchi, M. Fiore, 2007, Annals of Surgical Oncology.

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

L. Mariani, F. Perrone, A. Gloghini, 2016, Journal of Translational Medicine.

Circulating tumor markers: Predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei

M. Deraco, S. Kusamura, D. Baratti, 2013, Journal of surgical oncology.

Pseudomyxoma Peritonei: Biological Features Are the Dominant Prognostic Determinants After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

D. Nonaka, M. Deraco, S. Kusamura, 2009, Annals of surgery.

The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma

A. Gronchi, M. Deraco, S. Kusamura, 2015, Journal of surgical oncology.

Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?

M. Fiore, M. Deraco, S. Kusamura, 2010, Annals of Surgical Oncology.

Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

G. Salti, P. Sugarbaker, P. Sammartino, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes

M. Milione, F. Morano, F. Pietrantonio, 2022, Annals of Surgical Oncology.

Consensus statement on peritoneal mesothelioma

D. Bartlett, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

M. Deraco, S. Kusamura, A. Cabras, 2016, Annals of Surgical Oncology.

Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).

R. Bertulli, M. Deraco, S. Kusamura, 2013, European journal of cancer.

Locoregional treatment of peritoneal carcinomatosis from gastric cancer

Wiley Interscience, F. Bozzetti, M. Deraco, 2008, Journal of surgical oncology.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology.

L. Oñate-Ocaña, N. Petrelli, D. Shibata, 2007, Annals of surgical oncology.

Lymph Node Metastases in Diffuse Malignant Peritoneal Mesothelioma

M. Deraco, S. Kusamura, A. Cabras, 2009, Annals of Surgical Oncology.

Renal‐splenic shunt for intrahepatic caval occlusion after piggy‐back liver transplantation

V. Mazzaferro, A. Pulvirenti, E. Regalia, 1997 .

Renal-splenic shunt for infrahepatic caval occlusion after piggy-back liver transplantation

V. Mazzaferro, A. Pulvirenti, E. Regalia, 1997, Transplant international : official journal of the European Society for Organ Transplantation.

Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi‐institutional study

M. Solazzo, S. Bonomi, M. Deraco, 2012, BJOG : an international journal of obstetrics and gynaecology.

RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score

J. Tuynman, G. Salti, J. Briceño, 2019, Annals of Surgical Oncology.

Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?

V. Mazzaferro, L. Battaglia, M. Deraco, 2018, Diseases of the colon and rectum.

Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei

D. Morris, D. Elias, E. Levine, 2014, The British journal of surgery.

Multidimensional Analysis of the Learning Curve for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Surface Malignancies

M. Deraco, S. Kusamura, D. Baratti, 2012, Annals of surgery.

Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study

K. Campbell, A. Nissan, D. Morris, 2021, BMJ Open.

Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumors treated by cytoreductive surgery: Study protocol of a prospective, multi-center, observational study(PRECINCT- Patterns of peritoneal dissemination and REsponse to Chemotherapy IN patients

K. Campbell, A. Nissan, D. Morris, 2021, medRxiv.

Learning Curve, Training Program, and Monitorization of Surgical Performance of Peritoneal Surface Malignancies Centers.

L. Battaglia, M. Deraco, S. Kusamura, 2018, Surgical oncology clinics of North America.

Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients.

D. Elias, F. Gilly, G. Lorimier, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

E. Seregni, M. Deraco, S. Kusamura, 2007, Annals of Surgical Oncology.

Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Affect Long-term Outcome of Patients With Peritoneal Metastases From Colorectal Cancer: a Two-Center Study of 101 Patients

S. Bonomi, E. Leo, M. Deraco, 2014, Diseases of the colon and rectum.

Cytoreductive Surgery with Selective Versus Complete Parietal Peritonectomy Followed by Hyperthermic Intraperitoneal Chemotherapy in Patients with Diffuse Malignant Peritoneal Mesothelioma: A Controlled Study

M. Deraco, S. Kusamura, A. Cabras, 2012, Annals of Surgical Oncology.

Metabolic effects of liver transplantation in cirrhotic patients.

L. Groop, V. Mazzaferro, M. Taskinen, 1997, The Journal of clinical investigation.

Surgical Strategies in Colorectal Cancer Metastatic to the Liver

F. Bozzetti, D. Baratti, P. Bignami, 2000, Tumori.

Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma

D. Marrelli, L. Ansaloni, M. Deraco, 2023, Cancers.

Avidin-biotin system in Radioimmunoguided surgery for colorectal cancer

Felicia Zito, Ferruccio Fazio, Valerio Di Carlo, 1994, Diseases of the colon and rectum.

Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian Cancer: A Multi-Institutional Study

M. Solazzo, S. Bonomi, M. Deraco, 2013 .

Biological Features Are the Dominant Prognostic Determinants After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

D. Nonaka, M. Deraco, S. Kusamura, 2009 .

Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray

M. Deraco, S. Kusamura, A. Cabras, 2015, Annals of Surgical Oncology.

The nanomechanical fingerprint of colorectal cancer -derived peritoneal metastasis

M. Gariboldi, A. Podestà, M. Deraco, 2022, bioRxiv.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Patient with Peritoneal Mesothelioma and HIV Infection

F. Crippa, M. Deraco, S. Kusamura, 2010 .

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in a patient with peritoneal mesothelioma and HIV infection.

F. Crippa, M. Deraco, S. Kusamura, 2010, Tumori.

The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs.

M. Deraco, S. Kusamura, P. Rossi, 2012, Surgical oncology clinics of North America.

[Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research].

P. Casali, N. Zaffaroni, M. Deraco, 2003, Tumori.

Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan.

L. Mariani, M. Deraco, S. Kusamura, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma

S. Pilotti, F. Perrone, A. Belfiore, 2019, International journal of molecular sciences.

The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

S. Bonomi, D. Morelli, M. Deraco, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastases

M. Gariboldi, G. Pruneri, M. Pierotti, 2022, Journal of molecular cell biology.

Phase II randomized study on tissue distribution of cisplatin according to different levels of intra abdominal pressure during HIPEC: Preliminary results. NCT02949791

M. Deraco, S. Kusamura, G. Garrone, 2018, European Journal of Surgical Oncology.

External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification.

O. Sgarbura, V. Boige, K. Flatmark, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Is there an oncological interest in the combination of CRS / HIPEC for peritoneal carcinomatosis of HCC? Results of a Multicenter International Study

J. Spiliotis, P. Sugarbaker, L. Schwarz, 2018, HPB.

Surgery for colorectal cancer guided by radiodetecting probe. Clinical evaluation using monoclonal antibody B72.3.

I Sassi, F. Mangili, A. Siccardi, 1991, The European journal of surgery = Acta chirurgica.

Correlation between biological and mechanical properties of extracellular matrix from colorectal peritoneal metastases in human tissues

M. Gariboldi, A. Podestà, M. Deraco, 2023, Scientific reports.

Colobronchial fistula: an unusual complication after peritonectomy and hyperthermic intra-peritoneal chemotherapy (HIPEC).

M. Deraco, S. Kusamura, D. Baratti, 2009, In vivo.

Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

M. Vaira, M. Deraco, S. Kusamura, 2010 .

Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma.

M. Deraco, S. Kusamura, D. Baratti, 2009, In vivo.

Uterine Sarcoma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion: a Feasiblity Study

P. Casali, A. Gronchi, M. Deraco, 2004, Journal of chemotherapy.

Mytomicin-C, metronomic capecitabine and bevacizumab in patients with unresectable or relapsed Pseudomyxoma Peritonei of appendiceal origin

M. Milione, M. Nannini, F. Morano, 2023, Clinical Colorectal Cancer.

Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantation

V. Mazzaferro, A. Pulvirenti, E. Regalia, 2000, Hepatology.

Prevention and early treatment of peritoneal metastases from colorectal cancer: Second‐look laparotomy or prophylactic HIPEC?

M. Deraco, S. Kusamura, D. Baratti, 2014, Journal of surgical oncology.

Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

A. Scivales, M. Deraco, D. Baratti, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study.

D. Morelli, M. Deraco, S. Kusamura, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.

M. Deraco, S. Kusamura, D. Baratti, 2006, In vivo.

Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis

P. Faviana, M. Vaira, P. Sammartino, 2023, Annals of Surgical Oncology.

Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases

S. Franciscis, P. Faviana, M. Vaira, 2024, ESMO Open.

Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

M. Deraco, S. Kusamura, D. Baratti, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.